Ephraty L[au] - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Year	Number of Results
2007	1
2011	1
2012	1
2013	1
2015	1
2016	1
2021	1
2022	0

Page 1

Botulinum Injections for Idiopathic Cervical Dystonia: a Longitudinal Study.

Yahalom G, Fay-Karmon T, Livneh V, Israeli-Korn S, Ephraty L, Hassin-Baer S. Yahalom G, et al. Among authors: ephraty l. Neurotox Res. 2021 Aug;39(4):1352-1359. doi: 10.1007/s12640-021-00378-2. Epub 2021 May 29. Neurotox Res. 2021. PMID: 34050898

Repetitive deep transcranial magnetic stimulation for motor symptoms in Parkinson's disease: A feasibility study.

Cohen OS, Orlev Y, Yahalom G, Amiaz R, Nitsan Z, Ephraty L, Rigbi A, Shabat C, Zangen A, Hassin-Baer S. Cohen OS, et al. Among authors: ephraty l. Clin Neurol Neurosurg. 2016 Jan;140:73-8. doi: 10.1016/j.clineuro.2015.11.017. Epub 2015 Nov 24. Clin Neurol Neurosurg. 2016. PMID: 26658034

The Creutzfeldt-Jakob disease (CJD) neurological status scale: a new tool for evaluation of disease severity and progression.

Cohen OS, Prohovnik I, Korczyn AD, Ephraty L, Nitsan Z, Tsabari R, Appel S, Rosenmann H, Kahana E, Chapman J. Cohen OS, et al. Among authors: ephraty l. Acta Neurol Scand. 2011 Dec;124(6):368-74. doi: 10.1111/j.1600-0404.2011.01489.x. Epub 2011 Feb 8. Acta Neurol Scand. 2011. PMID: 21303352 Free PMC article.

Neuropsychiatric and cognitive features in autosomal-recessive early parkinsonism due to PINK1 mutations.

Ephraty L, Porat O, Israeli D, Cohen OS, Tunkel O, Yael S, Hatano Y, Hattori N, Hassin-Baer S. Ephraty L, et al. Mov Disord. 2007 Mar 15;22(4):566-9. doi: 10.1002/mds.21319. Mov Disord. 2007. PMID: 17260336

Neurological outcome in cerebrotendinous xanthomatosis treated with chenodeoxycholic acid: early versus late diagnosis.

Yahalom G, Tsabari R, Molshatzki N, Ephraty L, Cohen H, Hassin-Baer S. Yahalom G, et al. Among authors: ephraty l. Clin Neuropharmacol. 2013 May-Jun;36(3):78-83. doi: 10.1097/WNF.0b013e318288076a. Clin Neuropharmacol. 2013. PMID: 23673909

The LRRK2 G2019S mutation is associated with Parkinson disease and concomitant non-skin cancers.

Inzelberg R, Cohen OS, Aharon-Peretz J, Schlesinger I, Gershoni-Baruch R, Djaldetti R, Nitsan Z, Ephraty L, Tunkel O, Kozlova E, Inzelberg L, Kaplan N, Fixler Mehr T, Mory A, Dagan E, Schechtman E, Friedman E, Hassin-Baer S. Inzelberg R, et al. Among authors: ephraty l. Neurology. 2012 Mar 13;78(11):781-6. doi: 10.1212/WNL.0b013e318249f673. Epub 2012 Feb 8. Neurology. 2012. PMID: 22323743

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results